Radiation therapy is an integral part of the multidisciplinary management of breast cancer.
Regional lymph node irradiation in younger trials seems to provide superior target coverage …

Post-operative radiation therapy (RT) reduces loco-regional recurrence rates and mortality
in most patients with non-metastatic breast cancer. The aim of this critical review is to …

Background HYPORT adjuvant trial is a randomised phase III open-label noninferiority trial
comparing standard moderately hypofractionated 3 week adjuvant radiation therapy in …

Objective: Implement scripted automatic breast planning (AP) for breast techniques within
Raystation. Methods: Manual plans (MPs) were re-planned and compared with AP plans for …

Breast cancer is the most common cancer among women in India, and adjuvant
radiotherapy is an integral part of curative treatment in most patients. The recent decades …

Modern advances in diagnostics, surgery, systemic therapies, and radiotherapy (RT) have
drastically revolutionized treatment strategies for breast cancer. This review outlines current …

Purpose To report 5-year outcomes of a phase 2 trial of hypofractionated whole breast
irradiation (HF-WBI) completed in 3 weeks, inclusive of a sequential boost. Methods and …

Background We recently published 2-year results of the prospective, randomized IMRT-MC2
trial, showing non-inferior local control and cosmesis in breast cancer patients after …

Purpose We report treatment outcomes for patients who received adjuvant moderate
hypofractionated whole-breast radiation therapy with simultaneous integrated boost (SIB …

Background Hypofractionated radiotherapy is the current standard for adjuvant radiotherapy
across many centres. Further hypofractionation may be possible but remains to be …